Status:

ACTIVE_NOT_RECRUITING

Effects of Auditory Stimulation on Sleep and Memory in Schizophrenia

Lead Sponsor:

Massachusetts General Hospital

Conditions:

Schizophrenia

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

The investigators will test the hypothesis that auditory stimulation (playing quiet sounds during sleep) can normalize brain activity during sleep and improve memory in patients with schizophrenia. Th...

Eligibility Criteria

Inclusion

  • For healthy controls:
  • Male and female subjects
  • 18-50 years of age
  • Proficient in English
  • For schizophrenia patients:
  • Male and female schizophrenia outpatients
  • 18-50 years of age
  • Proficient in English
  • Able to give informed consent

Exclusion

  • Pregnant females
  • Current use of psychotropic medications (healthy controls only)
  • A history of head injury resulting in prolonged loss of consciousness or other neurological sequelae
  • IQ \<85
  • Neurological disorder (including seizure disorder)
  • Significant hearing or vision loss
  • Current substance abuse or dependence (nicotine abuse or dependence is not exclusionary)
  • Any unstable chronic medical condition that affects sleep
  • Diagnosed sleep disorder

Key Trial Info

Start Date :

April 13 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT04783571

Start Date

April 13 2020

End Date

December 31 2025

Last Update

January 14 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114